 | Up a level |
Hoeper, M. M., Ghofrani, H. -A., Benza, R. L., Corris, P. A., Gibbs, S., Klinger, J. R., Langleben, D., McLaughlin, V. V., Peacock, A., Rosenkranz, S., Vonk-Noordegraaf, A., White, J., Kleinjung, F., Meier, C. and Simonneau, G. (2017). Rationale And Design Of The Replace Trial: Riociguat Replacing Phosphodiesterase 5 Inhibitor (pde5i) Therapy Evaluated Against Continued Pde5i Therapy In Patients With Pulmonary Arterial Hypertension (pah). Am. J. Respir. Crit. Care Med., 195. NEW YORK: AMER THORACIC SOC. ISSN 1535-4970
Kiely, D. G., Cottreel, E., Galie, N., Tarcus, J. T., Peacock, A., Rosenkranz, S., Swift, A. J., Tawakol, A., Torbicki, A., Noordegraaf, A. Vonk, Wetherill, G. and Channick, R. (2021). REPAIR: LONG-TERM EFFECTS OF MACITENTAN ON THE RIGHT VENTRICLE (RV) IN PULMONARY ARTERIAL HYPERTENSION (PAH). Thorax, 76. S. A56 - 2. LONDON: BMJ PUBLISHING GROUP. ISSN 1468-3296
Noordegraaf, A. Vonk, Channick, R., Cottreel, E., Kiely, D., Martin, N., Moiseeva, O., Peacock, A., Tawakol, A., Torbicki, A., Rosenkranz, S. and Galie, N. (2020). Results from the REPAIR Study Final Analysis: Effects of Macitentan on Right Ventricular (RV) Remodelling in Pulmonary Arterial Hypertension (PAH). J. Heart Lung Transplant., 39 (4). S. S16 - 2. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1557-3117